What Is Adrenocortical Carcinoma (ACC) and How Do Families Plan for End of Life?

The short answer: Adrenocortical carcinoma (ACC) is a rare, aggressive cancer of the adrenal cortex. Most cases are diagnosed at advanced stages, and end-of-life planning should begin early — addressing hormonal symptoms, pain management, and family communication alongside curative efforts.

Understanding Adrenocortical Carcinoma

ACC accounts for fewer than 1% of all cancers but is highly aggressive. Tumors often produce excess cortisol, androgens, or aldosterone, causing Cushing's syndrome, virilization, or hypertension alongside cancer symptoms. Prognosis for metastatic ACC is poor, with median survival of 14–18 months.

Treatment Landscape and Prognosis

Mitotane remains the standard systemic agent; EDP-M (etoposide, doxorubicin, cisplatin + mitotane) is used for metastatic disease. Clinical trials, including immune checkpoint inhibitors, are being evaluated. Despite treatment, many patients progress to advanced disease within 1–2 years.

Hormonal Complications in End-of-Life Care

Hormonal excess from ACC can continue even in advanced disease — causing severe fatigue, muscle weakness, fluid retention, and mood changes. Palliative endocrinology support helps manage these symptoms alongside pain and other comfort measures.

Planning Ahead

Because ACC is rare and often unfamiliar to general practitioners, families benefit from connecting with NCI-designated cancer centers, joining ACC-specific patient communities, and beginning advance care planning early in the disease trajectory.

Frequently Asked Questions

What is the prognosis for stage IV adrenocortical carcinoma?

Metastatic ACC has a median overall survival of 12–18 months. However, some patients respond to mitotane-based therapy and achieve longer survival. Individual prognosis varies.

How is adrenocortical carcinoma treated?

Surgery is the primary treatment for localized disease. Mitotane is the main systemic drug; EDP-M chemotherapy is used for advanced stages. Clinical trials are ongoing.

Can a death doula help with ACC end-of-life planning?

Yes — death doulas help ACC families navigate the compressed timeline of a rare aggressive cancer, supporting legacy work, advance care planning, and emotional support for both patient and caregivers.

Where can I find ACC specialists?

NCI-designated cancer centers and academic medical centers with endocrine oncology programs offer the most specialized ACC care. The ACC Alliance (accalliance.org) is a patient advocacy resource.

Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.